China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999) — Capital Reinvestment Ratio
China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999) has a Capital Reinvestment Ratio of 2.38x as of September 2025, meaning it reinvests 2% of its operating cash flow (CN¥126.71 Million) in capital expenditures (CN¥302.02 Million). Check tangible net worth ratio of China Resources Sanjiu Medical & Pharmac to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
China Resources Sanjiu Medical & Pharmaceutical Co Ltd Capital Reinvestment Ratio (1999–2024)
This chart tracks China Resources Sanjiu Medical & Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 25 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of China Resources Sanjiu Medical & Pharmac.
Annual Capital Reinvestment Ratio for China Resources Sanjiu Medical & Pharmaceutical Co Ltd (1999–2024)
Year-by-year Capital Reinvestment Ratio for China Resources Sanjiu Medical & Pharmaceutical Co Ltd from 1999 to 2024. See 000999 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.18x | CN¥4.40 Billion | CN¥790.07 Million | ▼ -11.6% |
| 2023 | 0.20x | CN¥4.22 Billion | CN¥857.21 Million | ▼ -35.8% |
| 2022 | 0.32x | CN¥3.01 Billion | CN¥951.57 Million | ▼ -32.0% |
| 2021 | 0.47x | CN¥1.87 Billion | CN¥870.80 Million | ▲ +66.5% |
| 2020 | 0.28x | CN¥2.22 Billion | CN¥621.82 Million | ▲ +2.9% |
| 2019 | 0.27x | CN¥1.97 Billion | CN¥535.97 Million | ▼ -13.5% |
| 2018 | 0.31x | CN¥1.91 Billion | CN¥600.36 Million | ▲ +30.8% |
| 2017 | 0.24x | CN¥1.56 Billion | CN¥374.74 Million | ▼ -5.6% |
| 2016 | 0.25x | CN¥1.39 Billion | CN¥354.33 Million | ▼ -3.0% |
| 2015 | 0.26x | CN¥1.26 Billion | CN¥330.65 Million | ▼ -8.9% |
| 2014 | 0.29x | CN¥1.18 Billion | CN¥341.22 Million | ▲ +19.1% |
| 2013 | 0.24x | CN¥1.47 Billion | CN¥354.89 Million | ▼ -41.9% |
| 2012 | 0.42x | CN¥1.21 Billion | CN¥504.52 Million | ▼ -3.0% |
| 2011 | 0.43x | CN¥954.90 Million | CN¥409.79 Million | ▲ +34.8% |
| 2010 | 0.32x | CN¥848.28 Million | CN¥270.00 Million | ▲ +41.1% |
| 2009 | 0.23x | CN¥855.05 Million | CN¥192.93 Million | ▼ -79.1% |
| 2008 | 1.08x | CN¥1.12 Billion | CN¥1.20 Billion | ▲ +187.7% |
| 2007 | 0.37x | CN¥605.30 Million | CN¥226.78 Million | ▲ +17.4% |
| 2006 | 0.32x | CN¥425.51 Million | CN¥135.81 Million | ▼ -80.4% |
| 2005 | 1.63x | CN¥22.83 Million | CN¥37.14 Million | ▼ -66.4% |
| 2003 | 4.84x | CN¥28.09 Million | CN¥135.88 Million | ▲ +1289.6% |
| 2002 | 0.35x | CN¥496.12 Million | CN¥172.67 Million | ▼ -55.1% |
| 2001 | 0.77x | CN¥153.44 Million | CN¥118.83 Million | ▲ +21.2% |
| 2000 | 0.64x | CN¥266.86 Million | CN¥170.58 Million | ▲ +5.0% |
| 1999 | 0.61x | CN¥120.63 Million | CN¥73.43 Million | — |